NIBEC Co., Ltd. (KOSDAQ:138610)
South Korea flag South Korea · Delayed Price · Currency is KRW
31,700
-600 (-1.86%)
At close: Feb 13, 2026

NIBEC Revenue

NIBEC had revenue of 5.17B KRW in the quarter ending September 30, 2025, a decrease of -10.67%. This brings the company's revenue in the last twelve months to 32.96B, up 44.48% year-over-year. In the year 2024, NIBEC had annual revenue of 24.55B with 56.33% growth.

Revenue (ttm)
32.96B
Revenue Growth
+44.48%
P/S Ratio
10.93
Revenue / Employee
343.34M
Employees
96
Market Cap
360.30B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202424.55B8.85B56.33%
Dec 31, 202315.70B-5.97B-27.53%
Dec 31, 202221.67B8.05B59.04%
Dec 31, 202113.63B7.27B114.33%
Dec 31, 20206.36B-2.93B-31.55%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
GC Cell170.13B
HansBiomed89.78B
ISU Abxis66.39B
Genome & Company25.95B
S.Biomedics16.96B
Prestige Biologics13.36B
Y-Biologics3.61B
Vaxcell-Bio Therapeutics1.90B
Revenue Rankings